Tuberculosis Research and Treatment

Tuberculosis Research and Treatment / 2014 / Article

Research Article | Open Access

Volume 2014 |Article ID 302601 | https://doi.org/10.1155/2014/302601

Sangita C. Shelke, Prakash S. Adhav, Patrick K. Moonan, Matthew Willis, Malan A. Parande, Srinath Satyanarayana, Vikas D. Kshirsagar, Smita Ghosh, "Photovoice: A Novel Approach to Improving Antituberculosis Treatment Adherence in Pune, India", Tuberculosis Research and Treatment, vol. 2014, Article ID 302601, 4 pages, 2014. https://doi.org/10.1155/2014/302601

Photovoice: A Novel Approach to Improving Antituberculosis Treatment Adherence in Pune, India

Academic Editor: Paul R. Klatser
Received23 May 2014
Accepted11 Sep 2014
Published07 Oct 2014

Abstract

We compared antituberculosis treatment (ATT) adherence and outcomes among patients exposed to Photovoice (video of previously cured TB patients sharing experiences about TB treatment) versus those not exposed. The odds of successful outcome (i.e., cured or completing treatment) for the 135 patients who watched Photovoice were 3 times greater (odds ratio: 2.8; 95% CI: 1.3–6.1) than for patients who did not watch Photovoice. The comparison group, on average, missed more doses (10.9 doses; 95% CI: 6.6–11.1) than the intervention group who saw Photovoice (5.5 doses; 95% CI: 3.7–6.1). Using Photovoice at initiation of ATT has the potential to improve treatment adherence and outcomes.

1. Introduction

Tuberculosis (TB) requires successful completion of at least six months of antituberculosis treatment (ATT) [1]. Unfortunately, ATT compliance is difficult. Long treatment duration, common side effects of the medication, and other problems such as poverty and unemployment have been reported as potential barriers to ATT adherence [2]. ATT nonadherence leads to prolonged infectiousness, acquisition of drug resistance, relapse, lower cure rates, and higher mortality rates [3, 4]. In 2012, more than a third of the states in India reported that >20% of patients either lost to follow-up or were not cured at the conclusion of ATT [5], suggesting that a substantial proportion of patients are nonadherent to ATT.

ATT adherence often depends upon the patients’ general knowledge of TB, socioeconomic status, and whether they believe in the efficacy of the medication [6, 7]. Photovoice is an anthropologic storytelling method that allows participants to use mixed media to record and share personal experience to influence behavioural change and promote public health action [8]. In our study, we used video recordings to capture the personal experiences about tuberculosis treatment and treatment adherence of previously treated tuberculosis patients. We sought to determine if watching a Photovoice video before ATT would reduce the number of missed doses and improve treatment outcomes.

2. Methods

The study was conducted at BJGMC, Sassoon General Hospital, Government TB Treatment Centre. BJGMC treats approximately 4,000 tuberculosis patients per year and offers medical service to over 9 million people of the Pune, the second most populous district in Maharashtra state [9]. Utilizing the Photovoice approach [7], a 15-minute video was produced in Marathi, the local language spoken in Maharashtra. The video production, costing approximately $500, included eight previously cured patients expressing their personal stories about TB, their attitudes, perceptions and beliefs about ATT, and how ATT had a positive effect on their well-being and recovery from illness. All patients emphasized the benefits of treatment adherence and importance of completing ATT. We approached every third newly registered patient at BJGMC during January 1, 2011, to March 31, 2011, to participate in the study. After giving written informed consent, patients were shown the Photovoice video and initiated ATT as per national guidelines [5]. Every third treatment card of newly registered patient during January 1, 2010, to March 31, 2010, was reviewed as a comparison group. These patients had not viewed the Photovoice video. No other interaction with study investigators occurred after the start of treatment for both groups. New TB patients were defined as persons not previously treated for TB and in the first month of ATT. Previously treated patients were not approached to enroll nor were they included in the comparison group. After TB diagnosis all patients were referred to a Directly Observed Treatment Strategy (DOTS) centre located nearest to their residence. Each DOTS centre administers ATT and maintains a TB treatment card documenting the number of missed doses during TB treatment and treatment outcomes upon completion.

Demographic and clinical variables, number of doses prescribed, number of doses taken during treatment, and treatment outcomes were collected from the TB treatment cards of patients in both the Photovoice and comparison groups. Treatment outcomes were defined as successful or unsuccessful according to national treatment guidelines described elsewhere [5]. Successful treatment outcome included patients who were considered cured or who completed a full course of ATT. Unsuccessful treatment outcome included patients who failed treatment, transferred, lost to follow-up, or died during ATT [5].

Pearson chi-square and independent sample -tests were used to compare differences in proportions between successful and unsuccessful outcome among the Photovoice and comparison groups. Odds ratios (OR) were used to measure the association of Photovoice with sputum status at the end of the intensive phase (IP) and with treatment outcomes. All statistical tests were considered to be significant at an alpha of <0.05.

All patients were treated according to national guidelines irrespective of their participation or refusal to take part in the study. All data were safeguarded to protect patient confidentiality and no individual patient identifiers were retained electronically. The study protocol was approved by the International Union Against TB and Lung Disease (Paris, France) and the Institutional Review Board of BJGMC.

3. Results

Among 144 patients selected to view the Photovoice video, 135 (94%) consented to participate. In total, 276 patients (Photovoice group ; comparison group ) were studied. There were no significant differences in age, HIV status, or clinical presentation between Photovoice and comparison groups (Table 1). Almost two-thirds (76%) of the patients who watched the Photovoice video did not miss any doses compared to 47% among the comparison group (Table 1). A larger proportion of patients in the Photovoice group had successful treatment outcomes compared to the comparison group (93% versus 82%) (Table 1). The Photovoice group had three times the odds of successful treatment outcome compared to those who did not watch Photovoice (OR: 2.8, 95%  CI: 1.3–6.1) (Table 1).


CharacteristicsPhotovoiceComparisonTotal value
(%)(%)

Gender
 Male87(64.4)77(54.6)1640.096
 Female48(35.6)64(45.4)112
Age categories (years)
 <15 17(12.6)18(12.8)350.148
 15–2523(17.0)30(21.3)53
 26–3533(24.4)42(29.8)75
 36–4531(23.0)33(23.4)64
 46–5523(17.0)9(6.4)32
 >558(5.9)9(6.4)17
HIV status
 Positive45(33.3)41(29.1)860.743
 Negative66(48.9)74(52.5)140
 Unknown24(17.8)26(18.4)50
Type of tuberculosis
 Sputum positive pulmonary56(41.5)52(36.9)1080.423
 Sputum negative pulmonary 31(22.9)28(19.9)59
 Extrapulmonary 48(35.6)61(43.3)109
Total number of missed doses
 No missed doses102(75.6)66(46.8)168 0.000
 1 or more missed doses33(24.4)75(53.2)108
Sputum at the start of initiation phase1
 Negative81(60.0)95(67.4)1760.125
 Positive54(40.0)46(32.6)100
Sputum at the end of initiation phase1
 Negative133(98.5)124(87.9)2570.000
 Positive2(1.5)17(12.1)19
Treatment outcomes
 Successful 125(92.6)115(81.6)2400.000
 Unsuccessful210(7.4)26(18.4)36

Antituberculosis treatment (ATT) is comprised of 2 phases: intensive phase (IP) (24 doses of isoniazid, rifampicin, pyrazinamide, and ethambutol by directly observed therapy (DOT) thrice a week on alternate days for 8 weeks) and continuation phase (CP) (54 doses of isoniazid and rifampicin given thrice a week on alternate days with at least first dose of every week being directly observed). 2Patients with treatment failure and patients who transferred, lost to follow-up, or died.

Nearly all (99%) of the Photovoice patients converted sputum at the end of IP compared to 88% in the comparison group (Table 1). Patients who did not watch the video, on average, missed a greater number of doses during treatment (10.9 doses; 95% CI: 6.6–11.1) than patients in the intervention group (5.5 doses; 95% CI: 3.7–6.1) (Table 2).


(%)Mean number of total missed dosesMean difference1
Mean (SD)(95% CI)2

Overall ()
Photovoice
 Successful 125 (92.6)0.6 (1.3)4.9 (3.7–6.1)
 Unsuccessful310 (7.4)5.5 (4.9)
Comparison
 Successful 115 (81.6)2.1 (3.9)8.8 (6.6–11.1)
 Unsuccessful326 (18.4)10.9 (8.6)

Equal variances assumed. 2CI: confidence interval, SD: standard deviation. 3Patients with treatment failure and patients who transferred, lost to follow-up, or died.

4. Discussion

Several studies have described factors associated with ATT adherence but few studies describe the impact of interventions leading to behavioral changes that influence treatment outcomes [6]. This study was not a rigorous randomized controlled trial; however, these results reflect meaningful programmatic experience. Improved TB health-related education, along with efforts to reduce stigma, has been shown to improve patient health-seeking behaviours, lower treatment default rates, and bring about greater treatment completion [7, 9]. To our knowledge, this is the first time that Photovoice has been used to empower TB patients to share their personal experiences to influence ATT adherence. Having patients watch a 15-minute Photovoice video prior to initiation of ATT is a low-resource activity with the potential to improve medication adherence and long-term treatment outcomes.

5. Conclusion

Photovoice is a simple, inexpensive strategy that might be considered as one of Government of India’s Information, Education, and Communications activities to strengthen TB treatment adherence. In combination with other interventions, a Photovoice approach could be an effective tool for reduction of treatment lost to follow-up and other unsuccessful TB treatment outcomes.

Disclaimer

The findings and conclusions in this paper are those of the authors and do not necessarily represent views of the Centers for Disease.

Conflict of Interests

The authors declare that there is no conflict of interests regarding the publication of this paper.

Acknowledgments

The authors acknowledge the RNTCP Programme staff, Photovoice Advisory Committee members, the cured TB patients who worked on production of the Photovoice video, Dr. Pradeep Awate, and Mr Nagesh and his team for their relentless efforts in the making of the video and without their support this study would not be possible. The study was conducted as part of the “TB Operations Research Training Project” which aimed to build operational research capacity within the Government of India’s Revised National Tuberculosis Control Programme (RNTCP). This training project was conceived and implemented jointly by the Central Tuberculosis Division (Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India), the National Tuberculosis Institute (Directorate General of Health Services, Ministry of Health and Family Welfare, Government of India Bangalore, India), the World Health Organization (WHO, India Country Office), the International Union Against Tuberculosis and Lung Disease (The Union, South-East Asia Regional Office, New Delhi, India), and the US Centers for Disease Control and Prevention (CDC; Division of Tuberculosis Elimination, Atlanta, USA).

References

  1. World Health Organization, Guidelines for Treatment of Tuberculosis, WHO/HTM/TB/2010.05, WHO, Geneva, Switzerland, 4th edition, 2010.
  2. T. R. Frieden and J. A. Sbarbarob, “Promoting adherence to treatment for tuberculosis: the importance of direct observation,” Bulletin of the World Health Organization, vol. 85, no. 5, pp. 407–409, 2007. View at: Publisher Site | Google Scholar
  3. E. Sumartjo, “When tuberculosis treatment fails. A social behavioral account of patient adherence,” The American Review of Respiratory Disease, vol. 147, no. 5, pp. 1311–1320, 1993. View at: Google Scholar
  4. World Heath Organization, “Adherence to long-term therapies: evidence for Action,” in Tuberculosis, chapter 15, p. 145, World Heath Organization, Geneva, Switzerland, 2003, http://www.who.int/chp/knowledge/publications/adherence_section3.pdf. View at: Google Scholar
  5. Central TB Division, Annual Status Report, 2012, http://tbcindia.nic.in/pdfs/TB%20India%202012-%20Annual%20Report.pdf.
  6. J. Volmink and P. Garner, “Interventions for promoting adherence to tuberculosis management,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD000010, 2000. View at: Google Scholar
  7. S. Vijay, P. Kumar, L. S. Chauhan, B. H. Vollepore, U. P. Kizhakkethil, and S. G. Rao, “Risk factors associated with default among new smear positive TB patients treated under DOTS in India,” PLoS ONE, vol. 5, no. 4, Article ID e10043, 2010. View at: Publisher Site | Google Scholar
  8. C. Wang and M. A. Burris, “Photovoice: concept, methodology, and use for participatory needs assessment,” Health Education and Behavior, vol. 24, no. 3, pp. 369–387, 1997. View at: Publisher Site | Google Scholar
  9. “BJ Government Medical College,” http://www.bjmc.org/. View at: Google Scholar

Copyright © 2014 Sangita C. Shelke et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


More related articles

 PDF Download Citation Citation
 Download other formatsMore
 Order printed copiesOrder
Views1545
Downloads694
Citations

Related articles